Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 29, 2018 - Issue 3
Submit an article Journal homepage
449
Views
18
CrossRef citations to date
0
Altmetric
Psoriasis and dermatitis

Prescriptions for atopic dermatitis: oral corticosteroids remain commonplace

Tiffany AlexanderDepartment of Dermatology, Wake Forest School of Medicine, Center for Dermatology Research, Winston-Salem, NC, USA; View further author information
,
Elena MaximDepartment of Dermatology, Wake Forest School of Medicine, Center for Dermatology Research, Winston-Salem, NC, USA; View further author information
,
Leah A. CardwellDepartment of Dermatology, Wake Forest School of Medicine, Center for Dermatology Research, Winston-Salem, NC, USA; Correspondence[email protected]
View further author information
,
Aneesh ChawlaDepartment of Dermatology, Wake Forest School of Medicine, Center for Dermatology Research, Winston-Salem, NC, USA; View further author information
&
Steven R. FeldmanDepartment of Dermatology, Wake Forest School of Medicine, Center for Dermatology Research, Winston-Salem, NC, USA; ;Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA; ;Department of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USAView further author information
Pages 238-240 | Received 06 Jul 2017, Accepted 24 Jul 2017, Published online: 02 Oct 2017

References

  • Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol. 1999;103:125–138.
  • Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: Data from the 2003 National Survey of Children’s Health. J Invest Dermatol. 2011;131:67–73.
  • Bolognia J, Jorizzo J, Schaffer J. Dermatology. 3rd ed. London, UK: Elsevier Saunders; 2012.
  • McLean WHI. Filaggrin failure – from ichthyosis vulgaris to atopic eczema and beyond. Br J Dermatol. 2016;175(Suppl 2):4–7.
  • Bunikowski R, Mielke M, Skarabis H, et al. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol. 1999;103(1 Pt 1):119–124.
  • Denby KS, Beck LA. Update on systemic therapies for atopic dermatitis. Curr Opin Allergy Clin Immunol. 2012;12:421–426.
  • Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess (Rockv). 2000;4:1–191.
  • Levin C, Maibach HI. Topical corticosteroid-induced adrenocortical insufficiency: clinical implications. Am J Clin Dermatol. 2002;3:141–147.
  • Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347:1151–1160.
  • Ewing CI, Ashcroft C, Gibbs AC, et al. Flucloxacillin in the treatment of atopic dermatitis. Br J Dermatol. 1998;138:1022–1029.
  • Boguniewicz M. New strategies for dealing with staphylococcus aureus colonization and the emerging methicillin-resistant staphylococcus aureus epidemic in atopic dermatitis. Chem Immunol Allergy. 2012;96:113–119.
  • Klein PA, Clark RA. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol. 1999;135:1522–1525.
  • Aylett SE, Atherton DJ, Preece MA. The treatment of difficult atopic dermatitis in childhood with oral beclomethasone dipropionate. Acta Derm Venereol. 1992;176:123–125.
  • Heil PM, Maurer D, Klein B, et al. Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course - a randomized, placebo-controlled and double blind pilot study. J Dtsch Dermatol Ges. 2010;8:990–998.
  • Oldhoff JM, Darsow U, Werfel T, et al. Anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis. Allergy. 2005;60:693–696.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.